|
Volumn 133, Issue 2, 2009, Pages 101-111
|
Pharmacological profiles and clinical effects of oral sustained release beraprost sodium (Careload ®LA Tablets 60 μg, Berasus®LA Tablets 60 μg)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BERAPROST;
BERASUS;
CARELOAD;
CYCLIC AMP;
PLATELET DERIVED GROWTH FACTOR;
POLYCYCLIC AROMATIC HYDROCARBON;
PROSTACYCLIN;
UNCLASSIFIED DRUG;
DRUG DERIVATIVE;
VASODILATOR AGENT;
AREA UNDER THE CURVE;
DRUG ACTIVITY;
DRUG EFFECT;
DRUG RELEASE;
DRUG STRUCTURE;
HEALTH CARE ORGANIZATION;
IN VITRO STUDY;
MAXIMUM PLASMA CONCENTRATION;
REVIEW;
ANIMAL;
DELAYED RELEASE FORMULATION;
HUMAN;
PULMONARY HYPERTENSION;
RAT;
ANIMALS;
DELAYED-ACTION PREPARATIONS;
EPOPROSTENOL;
HUMANS;
HYPERTENSION, PULMONARY;
RATS;
VASODILATOR AGENTS;
|
EID: 63149128065
PISSN: 00155691
EISSN: 13478397
Source Type: Journal
DOI: 10.1254/fpj.133.101 Document Type: Review |
Times cited : (4)
|
References (43)
|